Additive effects of PTH and bisphosphonates on the bone healing response to metaphyseal implants in rats

Acta Orthopaedica

Volumn 79, Issue 1, 2008, Pages 111-115

  Aspenberg, Per ^a   Wermelin, Karin ^a   Tengwall, Pentti ^a   Fahlgren, Anna ^a  

^a LINKÖPING UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; PARATHYROID HORMONE[1-34]; STAINLESS STEEL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE REGENERATION; BONE REMODELING; CONTROLLED STUDY; DRUG EFFECT; DRUG POTENTIATION; FRACTURE FIXATION; FRACTURE HEALING; IMPLANT; MALE; METAPHYSIS; NONHUMAN; RAT;

ANIMALS; BONE DENSITY; BONE DENSITY CONSERVATION AGENTS; BONE REGENERATION; BONE REMODELING; BONE SCREWS; COATED MATERIALS, BIOCOMPATIBLE; DIPHOSPHONATES; FRACTURE HEALING; OSTEOPOROSIS; RATS; RATS, SPRAGUE-DAWLEY; TERIPARATIDE; TIBIA;

EID: 39449122790     PISSN: 17453674     EISSN: 17453682     Source Type: Journal    
DOI: 10.1080/17453670710014851     Document Type: Article

References (16)

1. Adolphson P, Abbaszadegan H, Boden H, Salemyr M, Henriques T. Clodronate increases mineralization of callus after Colles' fracture: a randomized, double-blind, placebo-controlled, prospective trial in 32 patients. Acta Orthop Scand 2000; 71 (2): 195-200.
2. Aspenberg P. Drugs and fracture repair. Acta Orthop 2005; 76 (6): 741-8.
3. Black D M, Greenspan S L, Ensrud K E, Palermo L, McGowan J A, Lang T F, Garnero P, Bouxsein M L, Bilezikian J P, Rosen C J. The effects of parathyroid hormone and alendronate alone or in combination in postmenopausal osteoporosis. N Engl J Med 2003; 349 (13): 1207-15.
4. Ettinger B, San Martin J, Crans G, Pavo I. Differential effects of teriparatide on BMD after treatment with raloxifene or alendronate. J Bone Miner Res 2004; 19 (5): 745-51.
5. Finkelstein J S, Hayes A, Hunzelman J L, Wyland J J, Lee H, Neer R M. The effects of parathyroid hormone, alendronate, or both in men with osteoporosis. N Engl J Med 2003; 349 (13): 1216-26.
6. Finkelstein J S, Leder B Z, Burnett S A, Wyland J J, Lee H, de la Paz A V, Gibson K, Neer R M. Effects of teriparatide, alendronate, or both on bone turnover in osteoporotic men. J Clin Endocrinol Metab 2006; 91 (8): 2882-7.
7. Gasser J A, Kneissel M, Thomsen J S, Mosekilde L. PTH and interactions with bisphosphonates. J Musculoskelet Neuronal Interact 2000; 1 (1): 53-6.
8. Jeppsson C, Astrand J, Tagil M, Aspenberg P. A combination of bisphosphonate and BMP additives in impacted bone allografts. Acta Orthop Scand 2003; 74 (4): 483-9.
9. Little D G, McDonald M, Bransford R, Godfrey C B, Amanat N. Manipulation of the anabolic and catabolic responses with OP-1 and zoledronic acid in a rat critical defect model. J Bone Miner Res 2005; 20 (11): 2044-52.
10. Ma Y L, Bryant H U, Zeng Q, Schmidt A, Hoover J, Cole H W, Yao W, Jee W S, Sato M. New bone formation with teriparatide [human parathyroid hormone-(1-34)] is not retarded by long-term pretreatment with alendronate, estrogen, or raloxifene in ovariectomized rats. Endocrinology 2003; 144 (5): 2008-15.
11. Samadfam R, Xia Q, Goltzman D. Co-treatment of PTH with osteoprotegerin or alendronate increases its anabolic effect on the skeleton of oophorectomized mice. J Bone Miner Res 2007; 22 (1): 55-63.
12. Skripitz R, Aspenberg P. Early effect of parathyroid hormone (1-34) on implant fixation. Clin Orthop 2001a; (392): 427-32.
13. Skripitz R, Aspenberg P. Implant fixation enhanced by intermittent treatment with parathyroid hormone. J Bone Joint Surg (Br) 2001b; 83 (3): 437-40.
14. Skripitz R, Aspenberg P. Parathyroid hormone - a drug for orthopedic surgery? Acta Orthop Scand 2004; 75 (6): 654-62.
15. Tengvall P, Skoglund B, Askendal A, Aspenberg P. Surface immobilized bisphosphonate improves stainless-steel screw fixation in rats. Biomaterials 2004; 25 (11): 2133-8.
16. Wermelin K, Suska F, Tengvall P, Thomsen P, Aspenberg P. Stainless steel screws coated with bisphosphonates gave stronger fixation and more surrounding bone. Histomorphometry in rats. Bone 2007 (in press).